Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cost-effectiveness of glatiramer acetate and interferon beta-1a for relapsing-remitting multiple sclerosis, based on the CombiRx study.
Rituximab for relapsing-remitting multiple sclerosis.
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.
Full Prescribing Information, Copaxone (glatiramer acetate)
Vitamin D3 attenuates oxidative stress and cognitive deficits in a model of toxic demyelination.
Synthesis of novel therapeutic agents for the treatment of multiple sclerosis: A brief overview.
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.
Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression.
CHMP issues positive opinion for TECFIDERA™ (dimethyl fumarate) as a first-line treatment for multiple sclerosis in the European Union
Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
Keystone Symposium on the Gut Microbiome: The Effector/Regulatory Immune Network
Management of women with multiple sclerosis through pregnancy and after childbirth.
Hypovitaminosis D upscales B-cell immunoreactivity in multiple sclerosis.
Salvianolic acid B protects the myelin sheath around injured spinal cord axons.
Teriflunomide
Alpha/beta interferon is a neuronal growth factor.
Genetic analysis of aquaporin-4 in neuromyelitis optica.
Induction of a Unique Isoform of the NCOA7 Oxidation Resistance Gene by Interferon β-1b.
The effects of prolonged wear of textured shoe insoles on gait, foot sensation and proprioception in people with multiple sclerosis: study protocol for a randomised controlled trial.
The role of pre-morbid intelligence and cognitive reserve in predicting cognitive efficiency in a sample of Italian elderly.
Testing the measurement invariance of the University of Washington Self-Efficacy Scale short form across four diagnostic subgroups.
Betaseron (Interferon Beta-1b) for SC Injection
Convergence through Complexity: How to Cure Brain Disease; Orion Bionetworks 2nd Annual Conference
Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder.
Dimethyl Fumarate and Monoethyl Fumarate Exhibit Differential Effects on KEAP1, NRF2 Activation, and Glutathione Depletion In Vitro.
Pages
« first
‹ previous
…
74
75
76
77
78
79
80
81
82
…
next ›
last »